Key result
Apixaban achieves partial regression of multiple LV thrombi at ~6 weeks without systemic embolization.
Why the study?
Left ventricular thrombus typically occurs with acute myocardial infarction, wall motion abnormalities, ventricular aneurysm, or severe systolic dysfunction, making its occurrence with preserved ventricular function and no obstructive coronary artery disease unusual.
Case Report (n=1)
Highlights an unusual association between mild acute pancreatitis and multiple left ventricular apical thrombi despite preserved LVEF (65%) and absence of obstructive coronary disease, successfully managed with apixaban.
Answers are grounded in this paper and cite their sources.
Apixaban may promote LV thrombus regression in pancreatitis with preserved EF; hypothesis-generating and requires prospective confirmation.
Left ventricular thrombus is most commonly associated with acute myocardial infarction, significant regional wall motion abnormalities, ventricular aneurysm, or severe left ventricular systolic dysfunction. Its occurrence in a patient with preserved ventricular function and no significant obstructive coronary artery disease is unusual. We report the case of a middle-aged patient who presented with mild acute pancreatitis and a mature pancreatic pseudocyst measuring 6.8×6.9×6.0 cm. During contrast- enhanced abdominal CT performed for evaluation of the pancreatic pathology, an incidental left ventricular apical filling defect was identified. Subsequent transthoracic echocardiography and cardiac magnetic resonance imaging confirmed multiple left ventricular apical thrombi, the largest measuring approximately 1.7 cm, despite a preserved left ventricular ejection fraction of 65% and absence of overt regional wall motion abnormality. Coronary angiography demonstrated non-obstructive coronary artery disease, with a 40% lesion in the left circumflex artery. A thrombophilia evaluation was non-contributory. In view of the known systemic prothrombotic effects of acute pancreatitis, pancreatic inflammation was considered a potential contributor to thrombus formation, although a direct causal relationship could not be established. The patient was treated with apixaban 5 mg twice daily following multidisciplinary cardiology and surgical assessment. Elective intervention for the pancreatic pseudocyst was deferred because of the competing thromboembolic and procedural bleeding risks. At 6-week follow-up, repeat echocardiography demonstrated partial regression of the thrombus without clinical evidence of systemic embolization. This case highlights an unusual association between acute pancreatitis and left ventricular thrombus formation in the absence of the conventional major cardiac substrates. It also emphasizes the importance of careful review of cardiac structures visible on abdominal cross-sectional imaging and the need for multidisciplinary decision-making when an intracardiac thrombus is identified in a patient requiring elective surgery.
No takes yet. Share an insight, caveat, or question.
Shivaganesham et al. (2026) conducted a case report in Multiple left ventricular apical thrombi in mild acute pancreatitis (n=1). Apixaban was evaluated on Thrombus regression and systemic embolization at 6-week follow-up. Apixaban twice daily achieved partial regression of multiple LV apical thrombi at 6 weeks without systemic embolization in a patient with LVEF 65% and acute pancreatitis.
Synapse has enriched 10 related papers. Consider them for comparative context: